Koers Panaxia Labs Israel Ltd TEL AVIV STOCK EXCHANGE
Aandelen
PNAX
IL0011043630
Beleggingsbeheer & Fondsbeheerders
Omzet 2022 | 39,42 mln. 10,61 mln. 9,85 mln. | Omzet 2023 | 19,59 mln. 5,27 mln. 4,89 mln. | Marktkapitalisatie | 22,44 mln. 6,04 mln. 5,61 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -43 mln. -11,57 mln. -10,74 mln. | Nettowinst (verlies) 2023 | -13 mln. -3,5 mln. -3,25 mln. | EV/omzet 2022 | 1,63 x |
Nettoschuld 2022 | 36,12 mln. 9,72 mln. 9,02 mln. | Nettoschuld 2023 | 36,1 mln. 9,71 mln. 9,02 mln. | EV/omzet 2023 | 2,99 x |
K/w-verhouding 2022 |
-0,65
x | K/w-verhouding 2023 |
-1,69
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 61,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dadi Segal
CEO | Chief Executive Officer | 48 | 01-10-19 |
Assi Rotbart
CHM | Chairman | 49 | 01-10-19 |
Director of Finance/CFO | 66 | 28-12-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michal Yageel
BRD | Director/Board Member | 54 | 29-12-21 |
Tal Yaron Eldar
BRD | Director/Board Member | 60 | 21-07-16 |
Michal Sapir
BRD | Director/Board Member | 66 | 17-03-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,26% | 94,17 mld. | |
+24,48% | 91,27 mld. | |
+19,64% | 27,7 mld. | |
-1,00% | 18,41 mld. | |
+15,26% | 15,55 mld. | |
+4,45% | 15,29 mld. | |
-20,31% | 12,49 mld. | |
+13,56% | 9,3 mld. | |
+24,50% | 9,29 mld. |